Medimmune Teams with NIH on Vaccines and Biogens TYSABRI(R) Receives Approval in European Union.
Publication: M2 Presswire
Publication Date: 30-JUN-06
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
M2 PRESSWIRE-30 June 2006-U.S. Equity News: Medimmune Teams with NIH on Vaccines and Biogens TYSABRI(R) Receives Approval in European Union(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:30062006
City of Industry, CA - Biotechnology industry alert provided by U.S. Equity News. Medimmune Inc. (Nasdaq:MEDI) said Thursday it is partnering with the National Institutes of Health to develop vaccines aimed at fighting respiratory illnesses. The drug developer entered into a cooperative research and development agreement with the National Institute of Allergy and...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
